INR 891.75
(2.58%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -143.47 Million INR | -148.54% |
2022 | -57.72 Million INR | -164.81% |
2021 | 89.07 Million INR | 4364.05% |
2020 | -2.08 Million INR | -107.62% |
2019 | 27.41 Million INR | -50.59% |
2018 | 55.48 Million INR | -23.66% |
2017 | 72.67 Million INR | 31.16% |
2016 | 55.41 Million INR | 6.85% |
2015 | 51.85 Million INR | 21.72% |
2014 | 42.6 Million INR | 36.12% |
2013 | 31.29 Million INR | 22.52% |
2012 | 25.54 Million INR | 0.0% |
2010 | 19.83 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -127.23 Million INR | -83.93% |
2023 FY | -143.47 Million INR | -148.54% |
2023 Q4 | -69.17 Million INR | -135.42% |
2023 Q1 | -28.37 Million INR | -7.7% |
2023 Q2 | -16.54 Million INR | 41.72% |
2023 Q3 | -29.38 Million INR | -77.65% |
2022 Q3 | -32.25 Million INR | -456.0% |
2022 FY | -57.72 Million INR | -164.81% |
2022 Q1 | -8.18 Million INR | 19.02% |
2022 Q2 | 9.06 Million INR | 210.68% |
2022 Q4 | -26.34 Million INR | 18.31% |
2021 Q1 | 33.65 Million INR | 561.96% |
2021 FY | 89.07 Million INR | 4364.05% |
2021 Q4 | -10.1 Million INR | -130.26% |
2021 Q3 | 33.4 Million INR | 4.0% |
2021 Q2 | 32.12 Million INR | -4.55% |
2020 FY | -2.08 Million INR | -107.62% |
2020 Q1 | 5.1 Million INR | -28.01% |
2020 Q2 | 10.17 Million INR | 99.24% |
2020 Q3 | -10.07 Million INR | -199.1% |
2020 Q4 | -7.28 Million INR | 27.72% |
2019 FY | 27.41 Million INR | -50.59% |
2019 Q4 | 7.09 Million INR | 86.56% |
2019 Q2 | 10.9 Million INR | 94.21% |
2019 Q1 | 5.61 Million INR | -51.16% |
2019 Q3 | 3.8 Million INR | -65.15% |
2018 Q4 | 11.49 Million INR | 319.37% |
2018 FY | 55.48 Million INR | -23.66% |
2018 Q3 | 2.74 Million INR | 0.0% |
2017 FY | 72.67 Million INR | 31.16% |
2016 Q1 | 14.18 Million INR | 0.0% |
2016 FY | 55.41 Million INR | 6.85% |
2015 FY | 51.85 Million INR | 21.72% |
2014 FY | 42.6 Million INR | 36.12% |
2013 FY | 31.29 Million INR | 22.52% |
2012 FY | 25.54 Million INR | 0.0% |
2010 FY | 19.83 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Biocon Limited | 10.22 Billion INR | 101.403% |
Blue Jet Healthcare Limited | 1.63 Billion INR | 108.762% |
Concord Biotech Limited | 3.08 Billion INR | 104.657% |
Dishman Carbogen Amcis Limited | -1.53 Billion INR | 90.65% |
Jubilant Ingrevia Limited | 1.82 Billion INR | 107.845% |
Lyka Labs Limited | -24.89 Million INR | -476.36% |
Panacea Biotec Limited | -11.73 Million INR | -1123.18% |
Piramal Pharma Limited | 178.2 Million INR | 180.516% |
SMS Lifesciences India Limited | 90.92 Million INR | 257.794% |
Supriya Lifescience Limited | 1.19 Billion INR | 112.046% |
Syngene International Limited | 5.1 Billion INR | 102.813% |
TAKE Solutions Limited | -1.19 Billion INR | 88.005% |